SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-043639
Filing Date
2021-11-09
Accepted
2021-11-09 16:05:16
Documents
2
Period of Report
2021-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3056
2 EX-24 DOCUMENT attachment1.htm EX-24 4770
  Complete submission text file 0000899243-21-043639.txt   9296
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address
Kumar Neil (Reporting) CIK: 0001742485 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40947 | Film No.: 211392027

Mailing Address C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY, CAMANA BAY GRAND CAYMAN E9 KY1-9009
Business Address C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY, CAMANA BAY GRAND CAYMAN E9 KY1-9009 1 345 949 9876
LianBio (Issuer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations